Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “CLIMACTERIC”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,171 records · Page 65Linked to original sources

[Hysteroscopy as a method of evaluation of endometrial pathology during climacteric ].

The Authors analyse 207 hysteroscopies performed in the outpatient clinic in women during menopause, without the use of dilatation or local anesthetic. The test was completed in 175 patients (84.6%). Tolerability was acceptable in 95% of cases. The main indication (80%) was atypical secretions during menopause or changes in the menstrual cycle. Hyperplastic lesions were confirmed in 12% of the tests carried out. An endometrial K was diagnosed in 5 cases (2.9%). The method showed a good level of specificity of diagnosis but it not always sufficiently sensitive. It is therefore necessary to complete the test by taking a selected histological sample using Novak's cannula.

Adult↗

[Action of low-dose estrogen and progestogen on the relief of climacteric symptoms and excretion of urinary calcium].

The effects of low-dose estrogen and progestogen on menopausal symptoms and urinary excretion of calcium were studied with Kuppermen score and fasting morning urine Calcium/Creatinine (Ca/Cr) ratio, respectively, in 69 perimenopausal women. The women were divided into 3 groups: amenorrhea less than 1 year (14 women); post menopause 1 approximately 3 years (19); and post menopause more than 3 years (36). Fasting urine Ca/Cr ratio in the postmenopausal group 1 approximately 3 years was 0.19 +/- 0.01, significantly higher than that (0.14 +/- 0.01) in the amenorrhea group less than 1 year and (0.11 +/- 0.006) the postmenopausal group more than 3 years. 18 women received sequentially 4 patterns of low-dose oral estrogen and progestogen: MPA 2 mg Q O D., EE 5 micrograms Q D, EE 5 micrograms Q O D, and EE 5 micrograms and MPA 2 mg Q O D alternately. Each pattern was used for 3 weeks and discontinued for an interval of two 2 weeks, then started the next pattern and so on EE 5 micrograms and MPA 2 mg Q O D alternately gave the best results both in improving symptoms and lowering urine Ca/Cr ratio. Seven women having intermittent large dose EE 50 micrograms every 10 days or Premarin 2.5 mg every 7 days had symptoms relieved but inconsistent decrease of urine Ca/Cr ratio.

Calcium↗

Abnormal bleeding in the climacteric.

In the perimenopausal years, we encounter a situation where the normal diminution in reproductive capacity, with its resulting disruption of the normal menstrual hormonal pattern, coincides with a very real risk of pelvic pathology. Limitation in the ability to diagnose and to treat these patients conservatively has in the past resulted in a high rate of hysterectomy. With increased understanding of the normal physiology of this stage of transition and with improved diagnostic tools, we are now able to come to a definitive diagnosis in most patients. This ability to assure the diagnosis has made it much easier to counsel the patient confidently about the appropriate course of action. We will continue to encounter the problem of hysterectomy for bleeding with no histologic lesion being found. Although reviewers' letters may be considered an unnecessary thorn in the side, the improved practice that has resulted from these efforts gives strong support to their continued activities. We can have confidence that our treatment plan evolved in a logical manner and offers our patients a high probability of benefit at justifiable risk.

Climacteric↗

Climacteric and menopause--medical point of view.

A discussion of the problems associated with the menopause and a regime to combat its effects is described. Treatment of the psychological aspects of menopause is stressed as well as the estrogen-replacement therapy.

Adult↗